Annual Shareholders Equity
$186.78 M
-$56.11 M-23.10%
December 31, 2023
Summary
- As of February 26, 2025, BRNS annual stockholders equity is $186.78 million, with the most recent change of -$56.11 million (-23.10%) on December 31, 2023.
- During the last 3 years, BRNS annual shareholders equity has risen by +$224.09 million (+600.72%).
- BRNS annual shareholders equity is now -25.92% below its all-time high of $252.13 million, reached on December 31, 2021.
Performance
BRNS Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$159.29 M
+$2.68 M+1.71%
September 30, 2024
Summary
- As of February 26, 2025, BRNS quarterly stockholders equity is $159.29 million, with the most recent change of +$2.68 million (+1.71%) on September 30, 2024.
- Over the past year, BRNS quarterly shareholders equity has stayed the same.
- BRNS quarterly shareholders equity is now -37.38% below its all-time high of $254.40 million, reached on June 1, 2022.
Performance
BRNS Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
BRNS Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -23.1% | 0.0% |
| 3 y3 years | +600.7% | -34.4% |
| 5 y5 years | +932.1% | -36.1% |
BRNS Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -25.9% | at low | -37.4% | +1.7% |
| 5 y | 5-year | -25.9% | +600.7% | -37.4% | +399.9% |
| alltime | all time | -25.9% | +600.7% | -37.4% | +399.9% |
Barinthus Biotherapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $159.29 M(+1.7%) |
| Jun 2024 | - | $156.62 M(-8.9%) |
| Mar 2024 | - | $171.83 M(-8.0%) |
| Dec 2023 | $186.78 M(-23.1%) | $186.78 M(-4.4%) |
| Sep 2023 | - | $195.40 M(-10.0%) |
| Jun 2023 | - | $217.21 M(-6.9%) |
| Mar 2023 | - | $233.30 M(-4.0%) |
| Dec 2022 | $242.90 M | $242.90 M(-0.4%) |
| Sep 2022 | - | $243.84 M(-4.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $254.40 M(+0.7%) |
| Mar 2022 | - | $252.74 M(+0.2%) |
| Dec 2021 | $252.13 M(-775.9%) | - |
| Dec 2021 | - | $252.13 M(+4.2%) |
| Sep 2021 | - | $241.98 M(-3.0%) |
| Jun 2021 | - | $249.39 M(-569.6%) |
| Mar 2021 | - | -$53.11 M(+42.4%) |
| Dec 2020 | -$37.30 M(+66.2%) | -$37.30 M |
| Dec 2019 | -$22.45 M | - |
FAQ
- What is Barinthus Biotherapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Barinthus Biotherapeutics?
- What is Barinthus Biotherapeutics annual shareholders equity year-on-year change?
- What is Barinthus Biotherapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Barinthus Biotherapeutics?
- What is Barinthus Biotherapeutics quarterly shareholders equity year-on-year change?
What is Barinthus Biotherapeutics annual stockholders equity?
The current annual shareholders equity of BRNS is $186.78 M
What is the all time high annual shareholders equity for Barinthus Biotherapeutics?
Barinthus Biotherapeutics all-time high annual stockholders equity is $252.13 M
What is Barinthus Biotherapeutics annual shareholders equity year-on-year change?
Over the past year, BRNS annual stockholders equity has changed by -$56.11 M (-23.10%)
What is Barinthus Biotherapeutics quarterly stockholders equity?
The current quarterly shareholders equity of BRNS is $159.29 M
What is the all time high quarterly shareholders equity for Barinthus Biotherapeutics?
Barinthus Biotherapeutics all-time high quarterly stockholders equity is $254.40 M
What is Barinthus Biotherapeutics quarterly shareholders equity year-on-year change?
Over the past year, BRNS quarterly stockholders equity has changed by $0.00 (0.00%)